Intuitive Surgical Inc
ISRG508.130USD
+20.200+4.14%
Cierre 04/24, 16:00（ET）Cotizaciones retrasadas 15 min
182.11BCap. mercado
78.41P/E TTM
Información de Intuitive Surgical Inc Compañía
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Información de la empresa
Código de la empresaISRG
Nombre de la empresaIntuitive Surgical Inc
Fecha de salida a bolsaJun 13, 2000
Fundada en1995
Director ejecutivoDr. Gary S. Guthart, Ph.D.
Número de empleados15638
Tipo de títulosOrdinary Share
Fin del año fiscalJun 13
Dirección1020 Kifer Road
CiudadSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94086
Teléfono14085232100
Sitio Webhttps://www.intuitive.com/en-us/about-us/company
Código de la empresaISRG
Fecha de salida a bolsaJun 13, 2000
Fundada en1995
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
2.04K
-54.69%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
1.61K
--
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
671.00
-18.27%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
240.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Por regiónUSD
Nombre
Ganancia
Proporción
U.S.
5.59B
66.92%
Outside of United states
2.76B
33.08%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.89%
Fidelity Management & Research Company LLC
2.93%
Other
74.78%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.89%
Fidelity Management & Research Company LLC
2.93%
Other
74.78%
Tipo
Accionista
Proporción
Investment Advisor
43.07%
Investment Advisor/Hedge Fund
35.63%
Bank and Trust
2.46%
Research Firm
2.40%
Pension Fund
2.20%
Hedge Fund
1.77%
Sovereign Wealth Fund
1.39%
Individual Investor
0.50%
Family Office
0.15%
Other
10.43%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
3382
322.69M
90.06%
-610.71K
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
2022Q4
2840
310.11M
87.74%
-7.77M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
32.06M
8.95%
+364.96K
+1.15%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
18.57M
5.18%
+488.70K
+2.70%
Dec 31, 2024
State Street Global Advisors (US)
15.31M
4.27%
+255.30K
+1.70%
Dec 31, 2024
T. Rowe Price Associates, Inc.
13.96M
3.9%
-133.51K
-0.95%
Dec 31, 2024
Fidelity Management & Research Company LLC
10.49M
2.93%
-117.40K
-1.11%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.76M
2.17%
+243.80K
+3.25%
Dec 31, 2024
Capital World Investors
7.43M
2.07%
+11.93K
+0.16%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
7.37M
2.06%
+98.84K
+1.36%
Feb 28, 2025
JP Morgan Asset Management
7.22M
2.01%
+123.15K
+1.74%
Dec 31, 2024
Fisher Investments
4.87M
1.36%
+86.49K
+1.81%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: sáb., 5 de abr
Hora de actualización: sáb., 5 de abr
Nombre
Proporción
Langar Global HealthTech ETF
19.52%
iShares U.S. Medical Devices ETF
13.37%
First Trust Nasdaq Lux Digi Health Solutions ETF
8.9%
Global X Robotics & Artificial Intelligence ETF
7.07%
Invesco AI and Next Gen Software ETF
7.04%
Goldman Sachs Future Health Care Equity ETF
6.3%
Neuberger Berman Disrupters ETF
6.01%
Franklin Intelligent Machines ETF
5.81%
iShares Health Innovation Active ETF
5.34%
Simplify Health Care ETF
4.99%
Ver más
Langar Global HealthTech ETF
Proporción19.52%
iShares U.S. Medical Devices ETF
Proporción13.37%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción8.9%
Global X Robotics & Artificial Intelligence ETF
Proporción7.07%
Invesco AI and Next Gen Software ETF
Proporción7.04%
Goldman Sachs Future Health Care Equity ETF
Proporción6.3%
Neuberger Berman Disrupters ETF
Proporción6.01%
Franklin Intelligent Machines ETF
Proporción5.81%
iShares Health Innovation Active ETF
Proporción5.34%
Simplify Health Care ETF
Proporción4.99%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
No datos encontrados
División de acciones
Fecha
Tipo
Relación
Aug 05, 2021
Split
1>3
Fecha
Tipo
Relación
Aug 05, 2021
Split
1>3